News for Healthier Living
Tpex cells: the game-changer in targeted tumor immunotherapy
Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ability to self-renew and rapidly proliferate. These cells have shown promise in expanding and differentiating into functional exhausted CD8+ T cells, significantly enhancing clinical outcomes. Understanding and leveraging Tpex cells can revolutionize immunotherapeutic strategies against cancer.
August 8, 2024
September 10 2024September 9 2024September 8 2024September 7 2024September 6 2024September 5 2024September 4 2024September 3 2024September 2 2024September 1 2024August 31 2024August 30 2024August 29 2024August 28 2024
|
|
|
|
|